Xience or Vision for the Management of Angina in the Elderly - XIMA


Most clinical trials in patients undergoing percutaneous coronary intervention (PCI) have had a poor representation of older patients. The current trial sought to compare outcomes after Xience (everolimus-eluting stent [EES]) versus Vision (bare-metal stent [BMS]) implantation in patients 80 years or older undergoing PCI.